Sierra Oncology, Inc. (SRRA) Social Stream
SIERRA ONCOLOGY INC (SRRA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SRRA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $45 | $29 | $35.8 | $54.99 | -34.9% |
| 2021-12-17 | 5 | $45 | $29 | $37 | $54.99 | -32.72% |
| 2022-01-21 | 5 | $45 | $32 | $37.6 | $54.99 | -31.62% |
| 2022-01-26 | 5 | $45 | $32 | $38 | $54.99 | -30.9% |
| 2022-03-11 | 5 | $51 | $37 | $43.6 | $54.99 | -20.71% |
| 2022-03-13 | 5 | $51 | $39 | $45.2 | $54.99 | -17.8% |
| 2022-04-13 | 4 | $55 | $55 | $55 | $54.99 | 0.02% |
The Trend in the Analyst Price Target
Over the past 23 months, SRRA's average price target has gone up $19.53.
SRRA reports an average of 50.68% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-10 | 2 | 46 | 26 | 32.50 | 19.88 | 63.48% |
| 2021-07-17 | 2 | 46 | 26 | 32.50 | 20.23 | 60.65% |
| 2021-08-14 | 2 | 46 | 27 | 32.75 | 19.80 | 65.4% |
| 2021-11-30 | 5 | 45 | 29 | 37.00 | 23.29 | 58.87% |
| 2022-04-13 | 5 | 55 | 55 | 55.00 | 54.75 | 0.46% |
SRRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 4 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
SRRA's average broker recommendation rating worsened by 2 over the prior 21 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, SIERRA ONCOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 16.79% of them.
- In the context of stocks in the small market cap category, SIERRA ONCOLOGY INC's average analyst price target is higher than 927.68% of them.
- SIERRA ONCOLOGY INC's variance in analysts' estimates is lower than -151.02% of Pharmaceutical Products stocks.
- SIERRA ONCOLOGY INC's number of analysts covering the stock is greater than 356.74% of Healthcare stocks.
Stocks similar to SIERRA ONCOLOGY INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SPRO, SPRB, and SNSE.
View All Top Stocks by Price Target
Is SRRA a Buy, Hold or Sell? See the POWR Ratings now!